Vident Investment Advisory’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,276
| Closed | -$425K | – | 1318 |
|
|
2023
Q1 | $425K | Sell |
23,276
-588
| -2% | -$10.7K | 0.01% | 829 |
|
|
2022
Q4 | $494K | Sell |
23,864
-5,289
| -18% | -$109K | 0.02% | 723 |
|
|
2022
Q3 | $759K | Sell |
29,153
-3,031
| -9% | -$78.9K | 0.02% | 670 |
|
|
2022
Q2 | $815K | Buy |
32,184
+3,059
| +11% | +$77.5K | 0.02% | 695 |
|
|
2022
Q1 | $919K | Buy |
29,125
+4,855
| +20% | +$153K | 0.02% | 722 |
|
|
2021
Q4 | $982K | Sell |
24,270
-34,311
| -59% | -$1.39M | 0.03% | 714 |
|
|
2021
Q3 | $2.04M | Sell |
58,581
-4,184
| -7% | -$146K | 0.06% | 399 |
|
|
2021
Q2 | $1.72M | Buy |
62,765
+7,621
| +14% | +$209K | 0.05% | 467 |
|
|
2021
Q1 | $1.55M | Sell |
55,144
-190
| -0.3% | -$5.33K | 0.05% | 482 |
|
|
2020
Q4 | $1.44M | Buy |
55,334
+10,356
| +23% | +$269K | 0.06% | 423 |
|
|
2020
Q3 | $771K | Sell |
44,978
-3,222
| -7% | -$55.2K | 0.04% | 558 |
|
|
2020
Q2 | $1.19M | Buy |
+48,200
| New | +$1.19M | 0.06% | 421 |
|
|
2018
Q4 | – | Sell |
-146,384
| Closed | -$2.04M | – | 892 |
|
|
2018
Q3 | $2.04M | Sell |
146,384
-9,755
| -6% | -$136K | 0.08% | 322 |
|
|
2018
Q2 | $1.91M | Buy |
+156,139
| New | +$1.91M | 0.08% | 327 |
|